Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
![](/images/homepage_main_image.png)
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is June 17, 2024.
All times in Eastern Daylight Time.
-
VCTC Kicks Off Plugfest to Advance Digital Keys by Enhancing Ultra-Wideband TechnologyHEFEI, China--(BUSINESS WIRE)--In a recent McKinsey Mobility Consumer Pulse survey, a majority of respondents, especially those in China, noted they are very likely to buy connectivity features in ... more »
-
Celltrion präsentiert auf dem EULAR 2024 vielversprechende Ergebnisse der Phase-III-Studie für CT-P47, einem Biosimilar-Kandidaten von RoActemra® (Tocilizumab) bei Patienten mit rheumatoider Arthritis (RA)INCHEON, Südkorea--(BUSINESS WIRE)--Celltrion präsentierte heute auf dem Europäischen Jahreskongress für Rheumatologie (EULAR) 2024 positive Phase-III-Daten für CT-P47, einen Biosimilar-Kandidaten,... more »
-
Celltrion laat veelbelovende resultaten zien in fase III-studie voor CT-P47, een biosimilar-kandidaat van RoActemra ® (tocilizumab) bij patiënten met reumatoïde artritis (RA) op EULAR 2024INCHEON, Zuid-Korea--(BUSINESS WIRE)--Celltrion heeft vandaag tijdens het jaarlijkse Europese congres over reumatologie (EULAR) 2024 positieve Fase III-gegevens gepresenteerd voor CT-P47, een biosi... more »
-
Celltrion présente à EULAR 2024 les résultats prometteurs d’une étude de phase III sur le CT-P47, un candidat biosimilaire de RoActemra® (tocilizumab), menée sur des patients atteints de polyarthrite rhumatoïde (PR)INCHEON, Corée du Sud--(BUSINESS WIRE)--Celltrion a présenté aujourd’hui au Congrès européen annuel de rhumatologie (EULAR) 2024 des résultats de Phase III positifs pour le CT-P47, un candidat bios... more »
-
Celltrion presenta risultati promettenti all'EULAR 2024 nello studio di fase III per CT-P47, candidato biosimilare di RoActemra® (tocilizumab) in pazienti affetti da artrite reumatoide (AR)INCHEON, Corea del Sud--(BUSINESS WIRE)--Celltrion ha presentato oggi i dati promettenti dello studio di Fase III per CT-P47, un candidato biosimilare che fa riferimento a RoActemra® in pazienti co... more »
-
Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024 more »
-
Juicy Stakes Casino Still the DaddyST JOHN’S, Antigua--(BUSINESS WIRE)--Juicy Stakes Casino is bringing you more poker than ever before this June – while dropping the daddy of all offers this week. Read on to find out all about it. ... more »
-
A Spectacle in NYC: Empire State Building Debuts 270-Foot Vhagar the Dragon Coiled Around the Building’s Mast, in Partnership with MaxNEW YORK--(BUSINESS WIRE)--A 270-foot-long dragon has landed in the center of New York City – atop the iconic Empire State Building (ESB). In partnership with Max, ESB has acknowledged that Vhagar ... more »
-
RBLX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Roblox Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Roblox business and prospects, resulting in its stock trading at inflated prices. more »
-
BreachBits Announces Agreement Between SentryMark and Nippon Telematique for Distribution of BreachRisk™ Solutions in JapanWASHINGTON--(BUSINESS WIRE)--BreachBits, Inc. announced a reseller partnership between SentryMark, Inc. and Nippon Telematique, Inc. (NTI) to distribute BreachRisk™ solutions in Japan. BreachBits d... more »
-
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trialWILMINGTON, Del.--(BUSINESS WIRE)--Positive results from the ECHO Phase III trial showed AstraZeneca’s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab demonstrated a stati... more »
-
Igloo Coolers präsentiert seine Produkte zur aktiven Kühlung auf der Spoga+GafaKÖLN, Deutschland--(BUSINESS WIRE)--Vom 16. bis 18. Juni präsentiert Igloo Coolers auf der Garten- und Grillmesse Spoga+Gafa in Halle 8, Stand D041, die elektrische Kompressorkühlgeräteserie ICF un... more »
-
CORRECTING and REPLACING Liby Master Fragrance from China Unlocks Premium Fragrance Market in GrassePARIS--(BUSINESS WIRE)--Please replace the release dated June 12, 2024 with the following corrected version due to multiple revisions. The updated release reads: LIBY MASTER FRAGRANCE FROM CHINA UN... more »
-
ATTENTION - RECTIFICATION : Revoici la dépêche corrigée: Le maître parfumeur chinois Liby inaugure le marché des parfums haut de gamme à GrassePARIS--(BUSINESS WIRE)--En mai 2024, le maître parfumeur Liby a été officiellement dévoilé à Grasse. La pittoresque ville de Grasse, dans le sud de la France, a accueilli son festival annuel de la ... more »
-
Akasa Air expands its presence in the Kingdom of Saudi Arabia; commences operations from RiyadhRIYADH, Saudi Arabia--(BUSINESS WIRE)--Akasa Air, India’s fastest-growing airline, commenced operations from Riyadh, connecting it to Mumbai with daily direct flights. more »